Previous Article | Next Article 
Infection and Immunity, December 2000, p. 6848-6856, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Released ATP Is an Extracellular Cytotoxic Mediator in
Salivary Histatin 5-Induced Killing of Candida
albicans
Svetlana E.
Koshlukova,1
Marcelo W. B.
Araujo,1
Didi
Baev,1 and
Mira
Edgerton1,2,*
Departments of Oral Biology1
and Restorative Dentistry,2 School
of Dental Medicine, State University of New York at Buffalo,
Buffalo, New York 14214
Received 19 May 2000/Returned for modification 11 August
2000/Accepted 7 September 2000
 |
ABSTRACT |
Salivary histatins (Hsts) are antifungal peptides with promise as
therapeutic agents against candidiasis. Hst 5 kills the fungal pathogen
Candida albicans via a mechanism that involves release of
cellular ATP in the absence of cytolysis. Here we demonstrate that
released ATP has a further role in Hst 5 killing. Incubation of the
cells with ATP analogues induced cell death, and addition of the ATP
scavenger apyrase to remove extracellular ATP released during Hst 5 treatment resulted in a reduction in cell killing. Experiments using
anaerobically grown C. albicans with decreased susceptibility to Hst 5 confirmed that depletion of cellular ATP as a
result of ATP efflux was not sufficient to cause cell death. In
contrast to Hst-susceptible aerobic cultures, anaerobically grown cells
were not killed by exogenously applied ATP. These findings established
that Hst binding, subsequent entry into the cells, and ATP release
precede the signal for cytotoxicity, which is mediated by extracellular
ATP. In a higher-eukaryote paradigm, released ATP acts as a cytotoxic
mediator by binding to membrane nucleotide P2X receptors. Based on a
pharmacological profile and detection of a C. albicans
60-kDa membrane protein immunoreactive with antibody to
P2X7 receptor, we propose that released ATP in response to
Hst 5 activates candidal P2X7-like receptors to cause cell death.
 |
INTRODUCTION |
Candida albicans is the
most prevalent human fungal pathogen causing severe mucosal and
systemic infections in hosts with compromised immune systems (5,
28). The toxicity of the currently used polyene antimycotic drugs
and emergence of resistant candidal species to the less toxic
azole-based agents have initiated a search for innate antibiotics as
alternative drug therapies. Innate host defense systems are
evolutionarily ancient and are characterized by production of potent
antimicrobial molecules that limit infections based on their capacity
to selectively discriminate pathogens from self species
(21). The first-line host defense of human saliva includes
many proteins with potent antibacterial and antifungal activity against
resident microflora in the oral cavity.
Histatins (Hsts) are 3- to 4-kDa structurally related histidine-rich
basic proteins of salivary acinar cell origin that are expressed only
in humans and higher subhuman primates (30). Hsts possess in
vitro antimicrobial activities, and their efficacy is highest for oral
yeasts, particularly C. albicans. Hst 3 (32 amino acids) and
Hst 5 (the N-terminal 24 amino acids of Hst 3 generated by proteolytic
cleavage) are the most potent candidacidal members of the family in
vitro, killing yeast and filamentous forms of Candida
species at physiological concentrations (15 to 30 µM) (32,
44). Salivary Hsts have potential as therapeutic agents in
patients with oral candidiasis, since they are potent antifungal agents
while being nontoxic to humans.
The physiological activities of the naturally occurring antimicrobial
peptides, such as magainins (26), cecropins (2), defensins (20, 22), and bactenecins (33), have
been ascribed to their effects on the microbial cell membrane. These
polypeptides adopt amphiphilic
-helical,
-sheet, or
poly-L-proline II structures and can form channels and
disrupt lipid bilayers. Salivary Hst 5, like other linear cationic
peptides, can form
-helices. However, it has been more difficult to
relate the antifungal activity of Hst 5 to the structural features of
its molecule. Extensive structural and conformational analyses of Hst 5 revealed that the weak amphipathic character of the helical structure
precludes spontaneous insertion into microbial membranes and direct
formation of pores or ion channels across the membrane (32,
34). Furthermore, Hst 5 variants with reduced killing ability
exhibited similar helical contents, suggesting that the
-helical
conformation is not solely responsible for optimal candidacidal
activity (42). A new insight into the potential mechanism of
Hst 5 candidacidal activity came from recent studies. We reported that
C. albicans expresses a class of functional binding sites
for salivary Hst 5, Hst 3, and Hst 4 and a 67-kDa yeast Hst 5 binding
protein (HstBP) (13). The discovery of a specific binding
protein on this yeast suggested a basis for the killing selectivity of
Hsts and their lack of toxicity to human host cells, Hst 3 and 5 binding to the fungal plasma membrane was thereafter proposed to be the
first event of a temperature- and ionic strength-dependent multistep
killing process involving subsequent internalization of the peptides
and interaction with an intracellular target(s) (19, 45).
Our approach to identify cellular targets by testing pharmacological agents for effects on Hst 5 candidacidal activity resulted in identification of three chemical uncouplers (carbonyl cyanide m-chlorophenylhydrazone [CCCP], dinitrophenol [DNP], and
azide) that inhibited Hst 5-induced killing of C. albicans
(23). Most importantly, this work uncovered a specific
cellular effect as a consequence of Hst 5 treatment that preceded cell
death. C. albicans exposed to physiological concentrations
of Hst 5 had a drastic reduction of intracellular ATP content, as a
result of efflux of cellular ATP. The major characteristic of Hst
5-induced ATP release was that it occurred while C. albicans
cells were metabolically active and had polarized membranes, thus
precluding cell lysis as a possible route by which ATP was released
from the cells (23).
The intracellular role of ATP has been recognized for many years;
however, under appropriate conditions many cell types release ATP in
the absence of cytolysis. Neurons and platelets release ATP by
exocytotic secretion, and epithelial and endothelial cells release ATP
through membrane ATP transporters (10, 41). Although little
is known about ATP-specific channels, members of the family of ATP
binding cassette (ABC) proteins have been implicated in conductive
transport of ATP (36, 38).
The finding that Hst 5 caused a release of cellular ATP in the absence
of cytolysis suggested a potential mechanism for its candidacidal
action. Massive loss of intracellular ATP alone may induce a series of
structural, biochemical, and functional alterations sufficient to
trigger irreversible necrotic cellular pathways (24).
Alternatively, extracellular ATP released from C. albicans in response to Hst 5 might have a further physiological role in cell
death. In higher eukaryotic cells extensive experimental evidence has
confirmed that released purine nucleotides and nucleosides interact
with cell surface receptors (purinoreceptors) (P1 receptors recognize
adenosine, and P2 receptors are activated by ATP) to induce a range of
biological effects (4, 15). The most striking property of
the membrane nucleotide receptors is their ability to mediate
cytotoxicity. Recent data have established that cells susceptible to
ATP-mediated cytotoxicity express either P2X1, or
P2X7 receptors (8, 14). Consistent with the
cytotoxic nucleotide receptor model, P2X agonists (ATP analogues)
caused loss of C. albicans viability, and the antagonists
suramin and pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid
prevented Hst 5-induced cell killing (23).
Here we extended the characterization of Hst 5-induced ATP release from
C. albicans and compared it to the depletion of
intracellular pools and cell killing. Experiments using anaerobically
grown C. albicans cells established that depletion of
cellular ATP, as a result of an ATP efflux, is not sufficient to cause
cell death and identified extracellularly released ATP as a cytotoxic mediator in Hst 5 yeast killing. Based on pharmacological and immunological evidence for presence of P2X7-like receptors
in C. albicans, we propose that ATP released in response to
Hst 5 may in turn activate yeast cytotoxic nucleotide receptors to
induce cell death.
 |
MATERIALS AND METHODS |
Materials.
C. albicans strain DS1 was isolated
from the palate of a denture stomatitis patient (32), and
strain 31531A was obtained from E. Rustashenko and F. Sherman,
Department of Biochemistry and Biophysics, University of Rochester.
Fluorescein isothiocyanate-labeled Hst 3 (FITC-Hst 3) was a gift from
Brian O'Connell (National Institute of Dental and Craniofacial
Research, Bethesda, Md.). Sabouraud dextrose agar and yeast
extract-peptone-dextrose (YPD) media were from Difco (Detroit,
Mich.); CCCP, 3'-O-(4-benzoylbenzoyl)-ATP (BzATP), ATP
S,
2-methylthioadenosine 5'-triphosphate (2MeSATP), ADP, AMP,
adenosine, and apyrase were from Sigma. ATP4
was from ICN
Biomedicals (Aurora, Ohio), and adenosine
5'-
,
-methylenetriphosphate (
,
-MeATP) was purchased from Fluka.
Hst synthesis and purification.
Hst 5 (DSHAKRHHGYKRKFHEKHHSHRGY) and Hst 3 (DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN) were synthesized using
standard solid-phase synthesis protocols and 9-fluorenylmethoxy
carbonyl chemistry and purified by reversed-phase high-performance
liquid chromatography as described previously (13).
Biotinylation of Hst 5 (biotin-Hst 5) was performed using
N-hydroxysuccinimidobiotin (Pierce).
N-hydroxysuccinimidobiotin (200 mg) was dissolved in 1.5 ml
of dimethylformamide and mixed with 400 mg of side chain-protected Wang
resin-Hst 5-NH2 at a molar ratio of 3:l. The coupling
reaction was carried out for 4 h at room temperature with
stirring. The completion of biotinylation was monitored using a Kaiser
test for detection of free amino groups. After filtering, three washes
with methylene chloride (50:50, vol/vol), and five washes with absolute
ethanol, biotin-Hst 5 deprotection, cleavage from the dried resin, and
purification by high-performance liquid chromatography were carried out
as described above. This procedure resulted in a specific incorporation of one biotin molecule into the free N-terminal amino group of the Hst
5 molecule, while the
-NH2 groups in four lysine
residues remained uncoupled. The purity of biotin-Hst 5 was assessed by sodium dodecyl sulfate-15% polyacrylamide gel electrophoresis (SDS-15% PAGE) using a Tris-Tricine electrode buffer and visualized by Western blotting with ExtrAvidin conjugated horseradish peroxidase and 4-chloro-1-naphthol (Sigma). Candidacidal bioassays verified that
biotin-Hst 5 and FITC-Hst 3 retained full biological activity.
Candidacidal assay.
C. albicans was maintained on
Sabouraud dextrose agar and grown in YPD or sucrose-salts-biotin yeast
synthetic medium as previously described (23). For cell
growth under anaerobic conditions, C. albicans cells were
inoculated in sucrose-salts-biotin yeast synthetic medium containing
Oxyrase (Oxyrase Inc., Mansfield, Ohio) and grown at 25°C according
to the manufacturer's instructions. Oxyrase in broth reduces the
O2 concentration to below 10 ppb within 30 min, removes any
reintroduced oxygen, and maintains this level of anaerobiosis for more
than 16 days. The antifungal activity of Hst 5 was examined by a
microdilution plate assay (23) with the following
modifications. Briefly, C. albicans cells were washed with
10 mM sodium phosphate buffer
(Na2HPO4-NaH2PO4) (pH
7.4) and resuspended at 5 × 105 cells/ml. Cell
suspensions were mixed with Hst 5 (31 µM) and incubated for 1.5 h at 37°C with shaking. Where indicated, apyrase (40 U/ml) was
included during the 1.5-h incubation of the cells with Hst 5. Candidacidal assays using nucleotide receptor agonists were carried out
for 3 h at 37°C. For experiments where cell killing was directly
compared to ATP release, (C. albicans (106
cells) was incubated for 1.5 h (unless indicated otherwise) at 37°C with Hst 5 (3.9 to 61 µM) in a final volume of 110 µl.
Control cultures were incubated with 10 mM phosphate buffer alone. Cell suspensions were diluted, and aliquots (500 cells) were spread onto
Sabouraud dextrose agar plates and incubated for 24 h at 37°C.
Candidacidal assays were performed in duplicate or triplicate. Cell
survival was expressed as a percentage of the control value, and loss
of viability was calculated as [1
(colonies from Hst 5-treated
cells/colonies from control cells)] × 100.
ATP bioluminescence assay.
ATP levels in cultures of
C. albicans were measured as described previously (1,
9) with the following modifications. C. albicans
(106 cells) was mixed with increasing concentrations of Hst
5 for various times in a final volume of 110 µl. For extracellular
ATP measurements, cells were pelleted (5,000 × g, 3 min), and 25 µl of the supernatant was pipetted into 210 µl of
boiling TE buffer (50 mM Tris, 2 mM EDTA, pH 7.8), boiled for an
additional 2 min, and stored on ice until assayed for ATP. Cell pellets
were then resuspended in 1 ml of TE buffer, 10 µl of the cell
suspension was diluted to 1 ml, and 50 µl (500 cells) was plated on
agar to assess viability as described above. Intracellular ATP
measurements were made on remaining cells (106) that were
washed twice with TE buffer, and cell pellets were submerged in liquid
nitrogen followed by the addition of 400 µl of boiling TE. The cells
were boiled for 4 min, subjected to another freeze-boil cycle, and
placed on ice until assayed for ATP. Extracellular and intracellular
ATP levels were measured by luminometry using an ATP assay kit (Sigma)
according to the manufacturer's instructions. A luciferin-luciferase
assay mix (100 µl) was added to 100 µl of cell lysates or 25 µl
of extracellular material in 96-well black microtiter plates (Wallac),
and light emission was monitored in a 1250 LKB-Wallac luminometer.
Results are expressed in bioluminescence relative light units, and ATP
concentrations were determined from ATP standard curves.
Overlay assays.
C. albicans cells were grown
under air or anaerobically in medium containing Oxyrase. Cells (2 × 108 to 5 × 108) were washed with 10 mM
phosphate buffer (pH 7.4) and resuspended in 100 µl of cold lysing
buffer (10 mM phosphate buffer [pH 7.4], 1 mM phenylmethylsulfonyl
fluoride, 1 mM EDTA, 1 µg of aprotinin per ml, 1 µg of pepstatin A
per ml, 1 µg of leupeptin per ml, and 1 µg of benzamidine per ml)
in tubes containing 100 µl of prechilled 0.5-mm-diameter glass-beads.
Cell-breakage was achieved by vigorous vortexing in five 2-min cycles
at 4°C. Cell lysates were clarified by centrifugation at 12,000 × g at 4°C and mixed with boiling Laemmli sample buffer.
Solubilized proteins were separated by SDS-PAGE and transferred to
polyvinylidene difluoride (PVDF) membranes for overlay assay. The
membranes were blocked with 1% milk in Tris-buffered saline (TTBS) (10 mM Tris-HCl [pH 7.5], 137 mM NaCl, 0.1% Tween 20), washed, and then
incubated for 2 h with 250 nM biotin-Hst 5 in binding buffer (10 mM Tris-HCl, pH 7.5). Blots were extensively washed in binding buffer
and then incubated for 1 h with ExtrAvidin-peroxidase at 1:5,000
in 1% bovine serum albumin in binding buffer to visualize the reactive biotinylated proteins.
Cell fractionation.
C. albicans cells were grown
overnight in 2 1 of YPD medium at 37°C, harvested by centrifugation,
and washed twice with 10 mM phosphate buffer (pH 7.4). Cells were
resuspended in 35 ml of cold lysing buffer and added to a 50-ml Bead
Beater chamber (Biospec, Bartlesville, Okla.) containing 25 ml of
prechilled 0.5-mm-diameter glass beads. Homogenization was carried out
in 10 1-min bursts at 4°C. The lysate was clarified at 20,000 × g. The crude membrane fraction was separated from the
soluble proteins by centrifugation for 1 h at 105,000 × g. The membrane pellet was washed and homogenized in lysing
buffer containing 1% Triton X-100. The membrane fraction and
cytoplasmic fraction (the high-speed supernatant) were lyophilized and
prior to electrophoresis were solubilized in Laemmli sample buffer.
Immunoblot detection of proteins.
Western blot membranes
were blocked in TTBS with 1% bovine serum albumin and incubated for
2 h with rabbit polyclonal anti-P2X7 serum (1:1,000)
or with anti-P2X1 serum (1:300). Anti-P2X7
serum was raised against the synthetic peptide corresponding to
residues 576 to 595 of the rat P2X7 protein, and
anti-P2X1 serum was raised against residues 382 to 399 of
rat P2X1 receptor (Alomone Labs, Jerusalem, Israel).
Following incubation with goat anti-rabbit immunoglobulin G conjugated
to horseradish peroxidase, the reactive proteins were visualized using
enhanced chemiluminescence (ECL, Amersham).
Confocal fluorescence microscopy.
FITC-Hst 3 was used to
examine Hst entry into C. albicans cells that were grown
under air or anaerobically in medium containing Oxyrase. Cells
(106) were treated for 1.5 h at 37°C with 15 µM
FITC-Hst 3 in 100 µl of 10 mM phosphate buffer, pH 7.4. Where
indicated, a 100-fold excess of Hst 5 was added as an unlabeled
competitor. The cells were then extensively washed and concentrated,
and living cells were mounted on slides with sealed coverslips. Optical
sections were collected using a laser scanning confocal imaging system (MRC 1024; Bio-Rad, Richmond, Calif.) with a fluorescein excitation line (488 nm) and filter systems to visualize FITC-tagged protein. The
images were taken at 0.5-µm cell sections.
 |
RESULTS |
Characterization of Hst 5-induced release of C. albicans ATP and cell killing.
We have previously
shown that Hst 5 killing of C. albicans is initiated with a
nonlytic release of ATP, which coincided with the depletion of cellular
ATP and correlated with cell death (23). We extended these
results by performing detailed time course and dose dependency studies
of Hst 5-induced release and depletion of intracellular ATP, while
aliquots of these cells were plated on agar to assess viability. This
approach allowed us to directly compare extracellular and intracellular
ATP levels to the number of surviving CFU, as well as permitting us to
account for variations in detected ATP by normalizing to the number of
control CFU (actual cell number present during incubation). ATP release
and depletion of intracellular ATP depended on the concentration of Hst
5 and the length of exposure to the cells. Incubation of C. albicans cells for 5 to 10 min with a relatively low concentration
of Hst 5 (3.9 µM) did not result in significant killing or in release or depletion of cellular ATP compared to untreated cells (Fig. 1A). Increased time of treatment caused a
gradual increase in cell killing (68% at 90 min), which corresponded
to a 55-fold increase in extracellular ATP and 42% depletion of
intracellular ATP (Fig. 1B and C). Within the first 5 min of treatment,
Hst 5 at a physiological concentration (31 µM) caused a 17% loss of cell viability and a six fold increase in extracellular ATP. Maximum release (100-fold increase in extracellular ATP) was observed following
30 min of Hst 5 (31 µM) exposure, which corresponded to an 85%
depletion of intracellular ATP and 82% loss of cell viability (Fig.
1). The level of released ATP after 90 min of incubation of the cells
with 31 µM Hst 5 represented over an 80-fold increase compared to the
control extracellular ATP level. This treatment resulted in a reduction
of the intracellular ATP level to approximately 6% of the ATP measured
in control cells and corresponded to complete cell killing as assessed
by the inability of the C. albicans cells to form colonies.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
Dose- and time-dependent induction of ATP release,
depletion of intracellular ATP, and killing of C. albicans
in response to Hst 5. C. albicans (106 cells,
strain DS1) was incubated with increasing concentrations of Hst 5 for
the indicated periods. Cell supernatants were then assayed for released
ATP by luminometry (B); cell pellets were diluted and aliquots were
plated on agar to assess viability (A), whereas the remaining cells
were used for determination of intracellular ATP (C). ATP was measured
in bioluminescence relative light units, and ATP concentrations
(picomoles/106 cells) were determined from ATP standard
curves. Loss of cell viability is expressed as [1 - (CFU of treated
cells/CFU of control cells)] × 100 (the average control CFU were
480 ± 62 for cells incubated in 10 mM phosphate buffer). Results
are means ± standard deviations from duplicates from three
independent experiments.
|
|
Culture anaerobiosis protects C. albicans from Hst 5 killing.
Recent studies demonstrated that Hst 5 killing of
C. albicans was partially inhibited when performed in an
anaerobic chamber (19). These results, together with the
finding that chemical uncouplers protected C. albicans from
Hst 5 killing (23), suggested that active mitochondrial
metabolism may sensitize cells to Hst 5. We therefore tested whether
anaerobically grown cells were susceptible to Hst 5. For these
experiments, cells were grown for 2 days in standard medium containing
the enzyme preparation Oxyrase to remove oxygen and create anaerobic
conditions. Respiration measurements confirmed culture anaerobiosis,
since C. albicans cells grown under these conditions did not
consume oxygen (data not shown). Furthermore, resumption of respiration
was not detected for at least 1 h after cells were washed free of
Oxyrase and resuspended in air-saturated medium. C. albicans
cells grown anaerobically exhibited about 60% (strain DSI)
(Table 1) and 57% ± 5% (strain 3153A)(n = 3)
reductions in killing when exposed for 1.5 h to 31 µM Hst 5, compared to cells grown in air-saturated medium. This protective effect
was not due to an interaction of Hst 5 with Oxyrase present in the
buffer, since increased survival (61% ± 2%)(n = 3 for strain DS1) was observed even when cells were washed of Oxyrase
before exposure to Hst 5 in aerated buffer.
Anaerobically grown cells express HstBP, transport Hst 5 intracellularly, and release ATP in response to Hst 5.
C.
albicans expresses functional binding sites for salivary Hsts
(13, 45) and a 67-kDa candidal Hst 5 binding protein (HstBP)
(13). In Saccharomyces cerevisiae, oxygen
independent of mitochondrial respiration modulates the expression of
iron uptake activities, and anaerobically grown cells lacked proteins associated with high-affinity iron uptake (18). Therefore,
we examined whether growth of C. albicans cells in the
absence of oxygen alters the level of HstBP. For these experiments,
proteins from C. albicans cell lysates were analyzed on PVDF
membranes with biotin-Hst 5. Biotin-Hst 5 bound to a 67-kDa protein
(Fig. 2) that was previously recognized
by 125I-Hst 5 in overlay and cross-linking experiments
(13). HstBP was not detected when membranes were incubated
only with ExtrAvidin conjugated to peroxidase, confirming that the
detected band did not represent an endogenously biotinylated C. albicans protein (data not shown). Overlay assays revealed that
anaerobically grown C. albicans cells expressed HstBp at
levels similar to those expressed by the susceptible aerobically grown
cells (Fig. 2). Thus, the 60% reduction in killing of anaerobic cells
when exposed to Hst 5 cannot be attributed to a down-regulation of
HstBP.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 2.
Anaerobically grown C. albicans cells express
HstBP. C. albicans (109 cells) was grown
aerobically (lanes a) or anaerobically (lanes b) in synthetic medium
containing Oxyrase. Proteins from whole cell lysates were separated by
SDS-7.5% PAGE. Half of the gel was stained with Coomassie brilliant
blue (left panel); the other half, containing identical lanes, was
transferred onto a PVDF membrane and incubated for 2 h with 250 nM
biotin-Hst 5 (right panel). Reactive biotinylated proteins were
visualized with an ExtrAvidin-peroxidase system. The molecular masses
(in kilodaltons) of protein standards are indicated to the left. The
level of HstBP was not significantly altered in anaerobic cultures as
assessed by densitometry scanning and normalization to unrelated
proteins migrating at 40 kDa to account for loading differences.
|
|
Studies using fluorescently labeled Hst 5 or Hst 3 have shown that
following binding, Hsts were transported across the yeast
plasma
membrane (
19,
45). Therefore, we examined whether the
observed reduction in killing of anaerobically grown cells reflected
an
inefficient uptake of Hst.
C. albicans cells were incubated
for 1.5 h with 15 µM FITC-labeled Hst 3 and examined for
intracellular
localization by confocal fluorescence microscopy. Both
Hst-susceptible
cells (aerobic cultures) and anaerobically grown cells
accumulated
FITC-Hst 3 intracellularly as evidenced by the punctate
peripheral
and discontinuous cytoplasmic pattern of fluorescence (Fig.
3).
While a substantial portion of
labeled Hst was clearly inside
the cell and concentrated at one cell
pole, the punctate staining
observed on the cell surface may represent
extracellularly bound
protein rather than material that has been
internalized. No fluorescence
was observed when these cells were
incubated with a 100-fold excess
of unlabeled Hst 5 before the addition
of FITC-Hst 3. The fact
that anaerobically grown cells displayed
patterns of fluorescent
intracellular localization of Hst similar to
those observed in
cells grown under air indicates that initial Hst
binding as well
as its intracellular transport occur in the cells with
reduced
susceptibility to killing.

View larger version (103K):
[in this window]
[in a new window]
|
FIG. 3.
Anaerobically grown C. albicans cells
internalize Hst. Single confocal images of C. albicans
cells (strain DS1) incubated with FITC-Hst 3 (15 µM) for 1.5 h
at 37°C are shown. Aerobically grown cells (A) and anaerobically
grown cells (B) display similar peripheral as well as cytoplasmic
labeling by FITC-Hst 3. (C) Cells treated with FITC-Hst 3 (15 µM)
in the presence of a 100-fold excess of unlabeled Hst 5. (D)
Phase-contrast image of C. albicans cells treated with
FITC-Hst 3.
|
|
We next measured the ability of Hst 5 to induce ATP efflux from
anaerobically grown cells, to further examine the cause of
their
protection against Hst 5 killing. Incubation of anaerobically
grown
C. albicans cells for 1.5 h with 31 µM Hst 5 caused a
marked
increase in extracellular ATP and a drastic depletion of
cellullar
ATP compared to the case for untreated anaerobically grown
cells
(Table
1). Furthermore, the effect
of Hst 5 on cellular ATP in
anaerobic cultures was very similar
quantitatively to that observed
on cells grown under air (Table
1).
However, ATP efflux from
aerobically grown cells resulted in complete
killing, whereas
despite equivalent release of cellular ATP, anaerobic
growth provided
about 60% protection from Hst 5-induced cell death
(Table
1).
Our previous studies using inhibitors of Hst 5 activity
established
a correlation between ATP release and killing of
C. albicans (
23).
However, the present experiments with
anaerobically grown cells
revealed that ATP release, although required,
is not sufficient
for cell death.
Agonists for ATP receptors kill C. albicans.
In
higher eukaryotic cells, ATP can be transported across the plasma
membrane in the absence of cytolysis through a channel-like pathway.
Released ATP in turn can function outside the cell as a signaling
molecule by binding to membrane nucleotide P2 receptors to cause
changes in membrane permeability and even cell death (11,
43). P2 antagonists prevented Hst 5-induced killing and P2
agonists induced loss of C. albicans viability
(23), suggesting that extracellular ATP released from the
cells in response to Hst 5 may be involved in yeast killing upon
activation of putative ATP receptors. We examined the ability and
potency of ATP and various P2 receptor subtype-selective agonists to
kill C. albicans (Table 2).
The cytotoxic effects of BzATP (P2X7 selective among P2X
subtypes) and ATP
S (a P2X agonist) were detectable at concentrations lower than 0.01 µM for both ATP analogues (Fig.
4). At a concentration of 1 µM, which
was the maximum extracellular concentration of ATP measured following
treatment with 31 µM Hst 5 (Fig. 1), both, BzATP and ATP
S killed
approximately 55% of C. albicans cells (Fig. 4). Increasing
the concentration of BzATP, ATP
S, or ATP4
(P2X7-selective agonists) up to 100 µM produced about 60 to 68% cell killing (Fig. 4 and Table 2). Even at high concentrations (500 µM) 2-MeSATP (a P2Y1-selective agonist),
,
-MeATP (an agonist for P2X1 and P2X3),
AMP, ADP, and adenosine were significantly less efficacious or
ineffective (Table 2). This pharmacological profile of agonist
responses is most similar to that for the P2X7 cytotoxic
receptor among the ATP receptor subtypes described for higher
eukaryotic cells (40).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 4.
BzATP and ATP S dose-dependent killing of C. albicans. C. albicans cells (strain DS1) were incubated
with increasing concentrations of nucleotide receptor agonists BzATP
and ATP S for 3 h at 37°C. Cell survival is expressed as a
percentage of the control value, and each data point is the mean ± standard deviation of duplicate determinations from three to seven
independent experiments.
|
|
Recognition of a 60-kDa candidal membrane protein by
anti-P2X7 antibody.
The cDNAs encoding human, rat, and
mouse P2X7 receptors have recently been isolated (6,
35, 40). P2X7 receptors are integral membrane
proteins possessing a unique cytoplasmic carboxyl-terminal domain which
is required for the lytic action of ATP. We employed a specific
antibody raised against the last 20 amino acids at the C terminus of
rat P2X7 protein to test for cross-reactivity with C. albicans proteins. The anti-P2X7 antibody recognized a 60-kDa protein in the membrane fractions prepared from two different C. albicans strains (Fig. 5A,
lanes 2 and 3) but did not cross-react with yeast cytoplasmic proteins
(Fig. 5A, lane 1). In control Western blots using protein lysates from
J774A.1 mouse macrophage cells expressing P2X7 receptors,
this antibody reacted with two major bands of approximately 76 and 39 kDa (Fig. 5D, lane 2). The slower-migrating 76-kDa component is similar
in size to the P2X7 protein detected in ATP-susceptible
microglial cells (14), and the staining of this band was
completely abolished by pretreatment of the antibody with the
immunizing peptide (data not shown). The immunoreactivity of the 60-kDa
candidal membrane protein was greatly reduced by preadsorption of the
antiserum with the cognate peptide (Fig.
6). In some experiments, a 100-kDa band
and a 30-kDa band were also detected. P2X1 is another ATP
receptor for which a role in cell death has been proposed
(8); however, antibody specific to P2X1 protein
did not produce a visible reaction with C. albicans proteins
(Fig. 5B).

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 5.
A 60-kDa C. albicans membrane protein
cross-reacts with P2X7-specific antibody. (A to C)
Proteins from C. albicans cytoplasmic (lanes 1, strain DS1)
or membrane (lanes 2, strain DS1; lanes 3, strain 3153A) fractions were
separated by SDS gel electrophoresis and transferred onto a PVDF
membrane. The membrane was cut into three parts, each containing
identical lanes, and probed with a polyclonal antiserum to the C
terminus of rat P2X7 receptor (1:1,000) (A) or with an
antiserum to the rat P2X1 receptor (1:300) (B) or were
stained with Coomassie blue (C). (D) C. albicans membrane
fraction (lane 1) and lysates from J774A.1 mouse macrophages (lane 2)
were probed with anti-P2X7 antibody and visualized by ECL.
The arrows indicate the positions of the 60-kDa candidal membrane
protein and the 76-kDa protein from J774A.1 cells recognized by the
anti-P2X7 antibody.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 6.
Specificity of anti-P2X7 immunoreactivity in
C. albicans cells. Equal amounts of protein from the
C. albicans membrane fraction (strain DS1) were separated
and transferred to PVDF. The blot was cut in the middle, and strips
were probed with P2X7 receptor antibody that had been
preincubated with the immunizing peptide (A) or with
anti-P2X7 antibody alone (B). Numbers on the left are
molecular masses in kilodaltons.
|
|
Extracellular ATP is a cytotoxic mediator for Hst 5 yeast
killing.
Although anaerobically grown cells were protected from
killing, their response to Hst was indistinguishable from susceptible aerobic cultures in that they expressed HstBP, internalized Hst, and
released ATP. These findings, together with the evidence for the
presence of a P2X7-like receptor in C. albicans,
raised the possibility that cell protection may be due to an alteration
in an ATP signaling cascade. If ATP was, in fact, a cytotoxic mediator, then exogenously applied ATP should not kill anaerobically grown cells.
Consistent with this prediction, incubation of anaerobically grown
cells with the P2X agonists BzATP or ATP
S at 100 µM did not result
in significant killing, whereas both ATP analogues induced about a 60%
decrease in survival of aerobic cultures (Hst 5-susceptible C. albicans cells) (Fig. 7). Thus, the
inability of anaerobically grown cells to respond to extracellular ATP
appears to be the cause for their reduced susceptibility to Hst 5.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 7.
Extracellular ATP is a cytotoxic agent for Hst
5-susceptible cells (aerobic cultures) but not for cells with reduced
susceptibility to Hst 5 (anaerobic cultures). C. albicans cells (strain DS1) were grown aerobically or
anaerobically as described for Fig. 2 and then incubated for 3 h
at 37°C with either Hst 5 (31 µM) or BzATP or ATP S (100 µM).
In all cases cell survival is expressed as a percentage of the control
value and each data point is the mean ± standard deviation of
duplicate determinations from four independent experiments.
|
|
The role of released ATP in Hst 5-induced cell killing was additionally
supported by experiments using the phosphatase apyrase
to eliminate ATP
from extracellular solution. Addition of apyrase
(40 U/ml) to the
aerobic cells during Hst 5 treatment protected
about 50% of the cells
from death (Table
2). Together, our results
suggest that Hst 5 binding
and subsequent entry into the cells,
as well as the induction of ATP
release, precede the signal for
cytotoxicity, which is mediated by the
extracellular
ATP.
 |
DISCUSSION |
We have previously reported that C. albicans cells
released ATP in response to Hst 5, which occurred in the absence of
cytolysis and correlated with cell death (23). In this study
we showed that depletion of cellular ATP as a result of an ATP efflux
is not sufficient to cause cell death and identified released ATP as an
extracellular cytotoxic mediator in the Hst 5-activated killing
pathway. This identification is based upon (i) the ability of
extracellularly applied ATP analogues to kill C. albicans
and (ii) the decrease in Hst-5-induced cell killing upon addition of
the phosphatase apyrase to eliminate ATP from extracellular solution.
Furthermore, we provide pharmacological and immunological evidence for
the presence of yeast membrane ATP receptors, which may be activated by
released ATP to induce cell death.
Analysis of ATP release from C. albicans revealed that
maximum ATP efflux (0.1 ± 0.03 fmol released/cell) occurred after
30 min of incubation with concentrations of Hst 5 found in saliva (31 µM), coincided with depletion of intracellular pools (85% reduction
of intracellular ATP), and correlated with cell killing (82% decrease
in cell viability) (Fig. 1). The intracellular concentration of ATP in
control cells was about 0.06 fmol/cell and was consistently measured
using published protocols for extraction of ATP from C. albicans (1, 9). Comparison of the maximum level of
extracellular ATP following 30 min of incubation with Hst 5 (31 µM)
and the amount of ATP measured in control cells showed that more ATP
was released than was available intracellularly in C. albicans. This difference may reflect a lower recovery of
intracellular ATP due to incomplete disruption of yeast cells or
hydrolysis of ATP by released cellular ATPases during the breakage of
the cells. Alternatively, the detected levels of extracellular ATP may
be a result of a gradual efflux of continuously synthesized ATP in the
cells. This notion is supported by our previous results that production
of new ATP via the mitochondrial oxidative phosphorylation in Hst 5-treated cells was carried out for at least 1 h after the maximum ATP release (23) without recovery of intracellular ATP
levels (Fig. 1).
In mammalian cells ABC proteins have been implicated to function as
ATP-specific channels (36, 38). C. albicans
expresses ABC transporters that are drug efflux pumps and confer
multidrug resistance (31). It is presently unknown how ATP
is released from C. albicans in response to Hst 5 and
whether ABC proteins are involved in conductive transport; however,
specific ATP release in yeast in response to toxic agents is not
unprecedented (16). S. cerevisiae released ATP
after treatment with the ionophore nigericin while the cell membrane
permeability was not altered (3), and a plasma membrane
ATP-specific transporter activated by the antibiotic mycobacillin was
purified from Aspergillus niger (7).
Perhaps the most intriguing aspect of the present study concerns the
functional significance of ATP efflux and the consequent depletion of
C. albicans intracellular pools in Hst 5-induced cell death.
Concentration of ATP in the cell is an indicator of viability, and
gradual depletion of cellular ATP leads to inhibition of macromolecule
synthesis followed by structural and functional alterations and cell
death (24). Therefore, Hst 5-induced massive loss of
intracellular ATP in turn may cause a series of biochemical alterations
that result in the inability of the cell to replicate or initiate
processes leading to later loss of cellular structure. Alternatively,
extracellular ATP released from C. albicans in response to
Hst 5 may have a further physiological role in cell death, analogous to
the higher-eukaryote paradigm where released ATP acts as a cytotoxic
mediator by binding to membrane nucleotide P2 receptors
(12). Our studies using anaerobically grown C. albicans cells established that depletion of cellular ATP as a result of an ATP efflux is not sufficient to cause cell death (Table
1). Although anaerobically grown C. albicans cells displayed reduced susceptibility to killing, they were indistinguishable from the
aerobic cultures in their response to Hst 5 in that they expressed
HstBP, internalized Hst, and released ATP, which caused a severe
reduction in intracellular ATP pools (Fig. 2 and 3; Table 1). Moreover,
the reduction in killing was not due to quantitative differences in ATP
concentrations, since the amount of available intracellular ATP in the
untreated anaerobic cells was very similar to that in aerobically grown
cells, as was the magnitude of ATP efflux and reduction of cellular ATP
content following Hst 5 treatment (Table 1). The anaerobic cultures
differed in their response to Hst 5 from cells grown under air in only
one aspect: they did not respond to extracellular ATP, as evidenced by
the inability of exogenously applied ATP analogues (BzATP or ATP
S)
to kill these cells (Fig. 7). In contrast, both ATP analogues induced about a 60% decrease in survival of aerobic cultures (Hst
5-susceptible C. albicans cells) (Fig. 7). The functional
role of released ATP in cell killing was further supported by the
finding that addition of an ATP-consuming enzyme such as apyrase, to
eliminate ATP from the extracellular solution during Hst 5 treatment,
greatly reduced death (Table 2). Apyrase hydrolyzes ADP as well
(37); however, neither ADP, AMP, nor adenosine when applied
exogenously had a significant effect on C. albicans
viability (Table 2). Together, our findings demonstrate that the
cytotoxic mediator in Hst 5 killing of C. albicans is
extracellularly released ATP.
Recent experimental evidence suggested that the candidacidal pathway
activated by salivary Hsts involves at least three steps: binding,
intracellular uptake, and interaction with cellular targets (19,
45). The duration of each of the steps, their contribution to
killing, and when and how the cells die are not well understood. Decreased susceptibility to Hsts is a common feature of anaerobically grown C. albicans (Table 1), respiratory (petite) mutants
(17), or cells pretreated with azide or the proton
ionophores CCCP and DNP (23). In yeast, proton ionophores
uncouple respiratory chain phosphorylation and induce endogenous
fermentation; azide functions dually as a respiratory inhibitor and
uncoupler (25, 27, 29, 39). It is notable that cells with
reduced susceptibility to Hst 5 lack or have inhibited mitochondrial
function. However, an interesting observation is that complete cellular
protection from Hst 5 killing was not achieved by alteration of
mitochondrial function (Table 1) (17, 23), suggesting that
additional pathways may be involved. Furthermore, the protective
mechanisms induced by culture anaerobiosis, C. albicans
mitochondrial mutation, or drug treatment may not be the same. It is
possible that inhibition of different steps in the Hst multistep
killing mechanism contributes to the reduction in cell killing in these
instances. Indeed, azide, CCCP, and DNP all prevented Hst 5-induced ATP
efflux, resulting in an increase in cell viability (23),
whereas the inability of anaerobically grown cells to respond to
extracellular ATP appeared to be the cause for their reduced
susceptibility to Hst 5 (Fig. 7).
Mammalian P2X7 receptor is a plasma membrane ion channel
and an ATP-gated pore, which can mediate ATP-induced cell death
(12, 40). We have previously reported that the nonselective
P2 antagonist suramin and
pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid, which is
relatively more selective for P2X7 antagonism, prevented Hst 5-induced killing of C. albicans (23). The
results presented here further implicate activation of C. albicans P2X7-like receptors by released ATP in
response to Hst 5 to cause cell death. Support for this model includes
evidence that (i) ATP4
, BzATP, and ATP
S were all
capable of killing C. albicans, while other P2 receptor
agonists were less effective or ineffective (Table 2), and (ii) an
antibody specific to the unique C terminus of the P2X7
protein recognized a 60-kDa candidal membrane protein (Fig. 5).
The maximum ATP concentration measured extracellularly following Hst 5 treatment (about 1 µM) resulted in nearly complete cell killing (Fig.
1), whereas exogenously applied agonists BzATP and ATP
S at 1 µM
produced about 55% killing (Fig. 4). This quantitative difference in
cell killing may reflect differences in the target cells themselves. In
the case of Hst 5-treated cells, the released ATP acts upon cells
already severely depleted of ATP, which may be more sensitive and more
prone to fast ATP-mediated killing. Hst 5 entry into the cells may also
activate another modulatory molecule that regulates receptor
sensitivity to ATP.
The 60-kDa protein immunoreactive with antibody to P2X7 was
observed only in the C. albicans membrane fraction, however,
the size of this protein is less than the apparent size of the
mammalian P2X7 proteins (Fig. 5). The subcellular location,
together with the specific recognition by the anti-P2X7
antibody but not by antibody to P2X1, characterized the
60-kDa protein as a strong candidate for the candidal cytotoxic
P2X7-like receptor. The 67-kDa Hst binding protein, a
presumptive component of the identified binding site for Hsts on
C. albicans, was also detected in the membrane fraction
(13). Preincubation of immobilized C. albicans proteins with anti-P2X7 antibody did not decrease the
binding of biotin-Hst 5 to HstBP (data not shown), thus confirming
that the 60-kDa antigen and HstBP are different proteins.
The main conclusion of the present work is that extracellular ATP
released in response to Hst 5 plays a role in cell killing. Collectively, our findings suggest that Hst 5 binding, subsequent entry
into C. albicans cells, and the induction of ATP release precede the signal for cytotoxicity, which is mediated by extracellular ATP. The ability of exogenous ATP to kill C. albicans and
the inhibition of Hst 5 cell killing by P2X antagonists (23)
or upon removal of extracellular ATP (by apyrase), together with the
identification of a candidal membrane P2X7-like protein,
support the concept that released ATP mediates killing through yeast
ATP receptors.
Clearly, the candidal cytotoxic nucleotide receptor model presented
above needs further experimental verification, and Hst 5 activation of
other pathways leading to cell death is also acknowledged. At present,
ATP receptors have been conclusively identified only in mammalian
cells. There are, however, indications that ATP might have been used
early in evolution as an extracellular messenger (4). Thus,
in light of the therapeutic potential of Hsts in treatment of
candidiasis, the pharmacological and immunological evidence for the
presence of candidal cytotoxic nucleotide receptors underscores the
importance of elaborating the molecular mechanism of this previously
unrecognized pathway of microbial death.
 |
ACKNOWLEDGMENTS |
We thank Jeremy Bruenn for insightful scientific input, Wade J. Sigurdson for advice and help on confocal fluorescence microscopy, Philip Loverde and Arvind Thakur for the use of their luminometer, and
Tracy Lloyd for technical assistance.
This work was supported by Public Health Service grants DE10641,
DE00406, and DE12159 from the National Institute of Dental and
Craniofacial Research (to M.E.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 310 Foster Hall,
SUNY at Buffalo Main Street Campus, 3435 Main St., Buffalo, NY 14214. Phone: (716) 829-3067. Fax: (716) 829-3942. E-mail:
edgerto{at}buffalo.edu.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Ansehn, S., and L. Nilsson.
1984.
Direct membrane-damaging effect of ketoconazole and tioconazole on Candida albicans demonstrated by bioluminescent assay of ATP.
Antimicrob. Agents Chemother.
26:22-25[Abstract/Free Full Text].
|
| 2.
|
Boman, H. G.
1995.
Peptide antibiotics and their role in innate immunity.
Annu. Rev. Immunol.
13:61-92[CrossRef][Medline].
|
| 3.
|
Boyum, B., and G. Guidotti.
1997.
Glucose-dependent, cAMP-mediated ATP efflux from S. cerevisiae.
Microbiology
143:1901-1908[Abstract/Free Full Text].
|
| 4.
|
Burnstock, G.
1996.
P2 purinoceptors: localization, function and transduction mechanisms.
Ciba Found. Symp.
198:1-29[Medline].
|
| 5.
|
Cannon, R. D.,
A. R. Holmes,
A. B. Mason, and B. C. Monk.
1995.
Oral candida: clearance, colonization or candidiasis?
J. Dent. Res.
74:1152-1161[Abstract/Free Full Text].
|
| 6.
|
Chessell, I. P.,
A. D. Simon,
A. D. Hibell,
A. D. Michel,
E. A. Barnard, and P. P. A. Humphry.
1998.
Cloning and functional characterisation of the mouse P2X7 receptor.
FEBS Lett.
439:26-30[CrossRef][Medline].
|
| 7.
|
Chowdhury, B.,
S. Bose,
S. Bhaduri, and S. Bose.
1997.
Isolation and properties of an ATP transporter from a strain of Aspergillus niger.
Eur. J. Biochem.
247:673-680[Medline].
|
| 8.
|
Chvatchko, Y.,
S. Valera,
J. Aubry,
T. Renno,
G. Buell, and J. Bonnefoy.
1996.
The involvement of an ATP-gated ion channel, P(2X1), in thymocyte apoptosis.
Immunity
5:275-283[CrossRef][Medline].
|
| 9.
|
Cockayne, A., and F. C. Odds.
1984.
Interactions of Candida albicans yeast cells, germ tubes and hyphae with human polymorphonuclear leukocytes in vitro.
J. Gen. Microbiol.
130:465-471[Abstract/Free Full Text].
|
| 10.
|
Colman, R.
1990.
Aggregin: a platelet ADP receptor that mediates activation.
FASEB J.
4:1425-1435[Abstract].
|
| 11.
|
Di Virgilio, F.
1995.
The P2Z purinoreceptor: an intriguing role in immunity, inflammation and cell death.
Immunol. Today
16:524-528[CrossRef][Medline].
|
| 12.
|
Di Virgilio, F.,
P. Chiozzi,
S. Falzoni,
D. Ferrari,
J.M. Sanz,
V. Venketaraman, and O. R. Baricordi.
1998.
Cytolytic P2X purinoceptors.
Cell Death Differ.
5:191-199[CrossRef][Medline].
|
| 13.
|
Edgerton, M.,
S. E. Koshlukova,
T. E. Lo,
B. G. Chrzan,
R. M. Straubinger, and P. A. Raj.
1998.
Candidacidal activity of salivary histatins: identification of a histatin 5-binding protein on Candida albicans.
J. Biol. Chem.
273:20438-20447[Abstract/Free Full Text].
|
| 14.
|
Ferrari, D.,
P. Chiozzi,
S. Falzoni,
M. DalSusino,
G. Collo,
G. Buell, and F. Di Virgilo.
1997.
ATP-mediated cytotoxicity in microglial cells.
Neuropharmacology
36:1295-1301[CrossRef][Medline].
|
| 15.
|
Fredholm, B. B.,
M. P. Abbracchio,
G. Burnstock,
J. W. Daly,
T. K. Harden,
K. A. Jacobson,
P. Leff, and M. Williams.
1994.
Nomenclature and classification of purinoreceptors.
Pharmacol. Rev.
46:143-156[Medline].
|
| 16.
|
Guidotti, G.
1996.
ATP transport and ABC proteins.
Chem. Biol.
3:703-706[CrossRef][Medline].
|
| 17.
|
Gyurko, C.,
U. Lendenmann,
R. Troxler, and F. Oppenheim.
2000.
Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.
Antimicrob. Agents Chemother.
44:348-354[Abstract/Free Full Text].
|
| 18.
|
Hassett, R.,
A. Romeo, and D. Kosman.
1998.
Regulation of high affinity iron uptake in yeast Saccharomyces cerevisiae. Role of dioxygen and Fe (II).
J. Biol. Chem.
273:7628-7636[Abstract/Free Full Text].
|
| 19.
|
Helmerhorst, E. J.,
P. Breeuwer,
W. van `t Hof,
E. Walgreen-Weterings,
L. C. J. M. Oomen,
E. C. I. Veerman,
A. V. N. Amerongen, and T. Abee.
1999.
The cellular target of histatin 5 on Candida albicans is the energized mitochondrion.
J. Biol. Chem.
274:7286-7291[Abstract/Free Full Text].
|
| 20.
|
Hill, C. P.,
J. Yee,
M.E. Selsted, and D. A. Eisenberg.
1991.
Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization.
Science
251:1481-1485[Abstract/Free Full Text].
|
| 21.
|
Hoffmann, J. A.,
F. C. Kafatos,
C. A. Janeway, and R. A. B. Ezekowitz.
1999.
Phylogenetic perspectives in innate immunity.
Science
284:1313-1318[Abstract/Free Full Text].
|
| 22.
|
Kagan, B. L.,
T. Ganz, and R. I. Lehrer.
1994.
Defensins: a family of antimicrobial and cytotoxic peptides.
Toxicology
87:131-149[CrossRef][Medline].
|
| 23.
|
Koshlukova, S. E.,
T. L. Lloyd,
M. W. B. Araujo, and M. Edgerton.
1999.
Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death.
J. Biol. Chem.
274:18872-18879[Abstract/Free Full Text].
|
| 24.
|
Lieberthal, W.,
S. Menza, and J. Levine.
1998.
Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells.
Am. J. Physiol.
274:F315-F327[Abstract/Free Full Text].
|
| 25.
|
Lohmeier-Vogel, E.,
K. Skoog,
H. Vogel, and B. Hahn-Hagerdal.
1989.
31P nuclear magnetic resonance study of the effect of azide on xylose fermentation by Candida tropicalis.
Appl. Environ. Microbiol.
55:1974-1980[Abstract/Free Full Text].
|
| 26.
|
Ludtke, S. J.,
K. He,
W. T. Heller,
T. A. Harroun,
L. Yang, and H. W. Huang.
1996.
Membrane pores induced by magainin.
Biochemistry
35:13723-13728[CrossRef][Medline].
|
| 27.
|
Noshiro, A.,
C. Rurwin,
M. Laux,
K. Nicolay,
W. A. Scheffers, and H. Holzer.
1987.
Mechanisms of stimulation of endogenous fermentation in yeast by carbonyl cyanide m-chlorophenylhydrazone.
J. Biol. Chem.
262:14154-14157[Abstract/Free Full Text].
|
| 28.
|
Odds, F. C.
1987.
Candida infections: an overview.
Crit. Rev. Microbiol.
15:1-5[Medline].
|
| 29.
|
Olson, V.,
R. Hansing, and D. McClary.
1976.
The role of metabolic energy in the lethal action of basic proteins on Candida albicans.
Can. J. Microbiol.
23:166-174.
|
| 30.
|
Oppenheim, F. G.,
T. Xu,
F. McMillian,
S. M. Levitz,
R. D. Diamond,
G. D. Offner, and R. F. Troxler.
1988.
Histatins, a novel family of histidine-rich proteins in human parotid secretion.
J. Biol. Chem.
263:7472-7477[Abstract/Free Full Text].
|
| 31.
|
Prasad, R.,
P. Wergifosse,
A. Goffeau, and E. Balzi.
1995.
Molecular cloning and characterization of a novel gene of C. albicans, CDR1, conferring multiple resistance to drugs and antifungals.
Curr. Genet.
27:320-329[CrossRef][Medline].
|
| 32.
|
Raj, P. A.,
M. Edgerton, and M. J. Levine.
1990.
Salivary histatin 5 dependence of sequence, chain length and helical conformation for candidacidal activity.
J. Biol. Chem.
265:3898-3905[Abstract/Free Full Text].
|
| 33.
|
Raj, P. A.,
E. Marcus, and M. Edgerton.
1996.
Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.
Biochemistry
35:4314-4325[CrossRef][Medline].
|
| 34.
|
Raj, P. A.,
E. Marcus, and D. K. Sukumaran.
1998.
Structure of human salivary histatin 5 in aqueous and nonaqueous solutions.
Biopolymers
45:51-67[CrossRef][Medline].
|
| 35.
|
Rassendren, F.,
G. Buell,
C. Virginio,
R. A. North, and A. Surprenant.
1997.
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA.
J. Biol. Chem.
272:5482-5486[Abstract/Free Full Text].
|
| 36.
|
Roman, R. M.,
Y. Wang,
S. D. Lidofsky,
A. P. Feranchak,
N. Lomri,
B. F. Scharschmidt, and J. G. Fitz.
1997.
Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume.
J. Biol. Chem.
272:21970-21976[Abstract/Free Full Text].
|
| 37.
|
Schlosser, S.,
A. Burgstahler, and M. Nathanson.
1996.
Isolated rat hepatocytes can signal to other hepatocytes and bile duct cells by release of nucleotides.
Proc. Natl. Acad. Sci. USA
93:9948-9953[Abstract/Free Full Text].
|
| 38.
|
Schwiebert, E. M.,
M. E. Egan,
T.-H. Hwang,
S. B. Fulmer,
S. S. Allen,
G. R. Cutting, and W. B. Guggino.
1995.
CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP.
Cell
81:1063-1073[CrossRef][Medline].
|
| 39.
|
Serrano, R.
1977.
Energy requirements for maltose transport in yeast.
Eur. J. Biochem.
80:97-102[Medline].
|
| 40.
|
Surprenant, A.,
F. Rassendren,
E. Kawashima,
R. A. North, and G. Buell.
1996.
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7).
Science
272:735-738[Abstract].
|
| 41.
|
Todorov, L. D.,
S. Mihaylova-Todorova,
T. D. Westfall,
P. Sneddon,
C. Kennedy,
R. A. Bjur, and D. P. Westfall.
1997.
Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation.
Nature
387:76-79[CrossRef][Medline].
|
| 42.
|
Tsai, H.,
P. A. Raj, and L. A. Bobek.
1996.
Candidacidal activity of recombinant salivary histatin-5 and variants.
Infect. Immun.
64:5000-5007[Abstract].
|
| 43.
|
Wang, Y.,
R. Roman,
S. D. Lidofsky, and J. G. Fitz.
1996.
Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation.
Proc. Natl. Acad. Sci. USA
93:12020-12025[Abstract/Free Full Text].
|
| 44.
|
Xu, T.,
S. M. Levitz,
R. D. Diamond, and F. G. Oppenheim.
1991.
Anticandidal activity of major salivary histatins.
Infect. Immun.
59:2549-2554[Abstract/Free Full Text].
|
| 45.
|
Xu, Y.,
I. Ambudkar,
H. Yamagushi,
W. Swam,
T. Walsh, and B. O'Connell.
1999.
Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization.
Antimicrob. Agents and Chemother.
43:2256-2262[Abstract/Free Full Text].
|
Infection and Immunity, December 2000, p. 6848-6856, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chaffin, W. L.
(2008). Candida albicans Cell Wall Proteins. Microbiol. Mol. Biol. Rev.
72: 495-544
[Abstract]
[Full Text]
-
Helmerhorst, E. J., Venuleo, C., Sanglard, D., Oppenheim, F. G.
(2006). Roles of Cellular Respiration, CgCDR1, and CgCDR2 in Candida glabrata Resistance to Histatin 5. Antimicrob. Agents Chemother.
50: 1100-1103
[Abstract]
[Full Text]
-
Crane, J. K., Naeher, T. M., Choudhari, S. S., Giroux, E. M.
(2005). Two pathways for ATP release from host cells in enteropathogenic Escherichia coli infection. Am. J. Physiol. Gastrointest. Liver Physiol.
289: G407-G417
[Abstract]
[Full Text]
-
Baev, D., Rivetta, A., Vylkova, S., Sun, J. N., Zeng, G.-F., Slayman, C. L., Edgerton, M.
(2004). The TRK1 Potassium Transporter Is the Critical Effector for Killing of Candida albicans by the Cationic Protein, Histatin 5. J. Biol. Chem.
279: 55060-55072
[Abstract]
[Full Text]
-
Lupetti, A., Brouwer, C. P. J. M., Dogterom-Ballering, H. E. C., Senesi, S., Campa, M., van Dissel, J. T., Nibbering, P. H.
(2004). Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin. J Antimicrob Chemother
54: 603-608
[Abstract]
[Full Text]
-
Dong, J., Vylkova, S., Li, X.S., Edgerton, M.
(2003). Calcium Blocks Fungicidal Activity of Human Salivary Histatin 5 through Disruption of Binding with Candida albicans. JDR
82: 748-752
[Abstract]
[Full Text]
-
Baev, D., Rivetta, A., Li, X. S., Vylkova, S., Bashi, E., Slayman, C. L., Edgerton, M.
(2003). Killing of Candida albicans by Human Salivary Histatin 5 Is Modulated, but Not Determined, by the Potassium Channel TOK1. Infect. Immun.
71: 3251-3260
[Abstract]
[Full Text]
-
Bobek, L. A., Situ, H.
(2003). MUC7 20-Mer: Investigation of Antimicrobial Activity, Secondary Structure, and Possible Mechanism of Antifungal Action. Antimicrob. Agents Chemother.
47: 643-652
[Abstract]
[Full Text]
-
Fitzgerald, D. H., Coleman, D. C., O'Connell, B. C.
(2003). Susceptibility of Candida dubliniensis to Salivary Histatin 3. Antimicrob. Agents Chemother.
47: 70-76
[Abstract]
[Full Text]
-
Lupetti, A., Paulusma-Annema, A., Welling, M. M., Dogterom-Ballering, H., Brouwer, C. P. J. M., Senesi, S., van Dissel, J. T., Nibbering, P. H.
(2003). Synergistic Activity of the N-Terminal Peptide of Human Lactoferrin and Fluconazole against Candida Species. Antimicrob. Agents Chemother.
47: 262-267
[Abstract]
[Full Text]
-
Baev, D., Li, X. S., Dong, J., Keng, P., Edgerton, M.
(2002). Human Salivary Histatin 5 Causes Disordered Volume Regulation and Cell Cycle Arrest in Candida albicans. Infect. Immun.
70: 4777-4784
[Abstract]
[Full Text]
-
Lupetti, A., Paulusma-Annema, A., Senesi, S., Campa, M., van Dissel, J. T., Nibbering, P. H.
(2002). Internal Thiols and Reactive Oxygen Species in Candidacidal Activity Exerted by an N-Terminal Peptide of Human Lactoferrin. Antimicrob. Agents Chemother.
46: 1634-1639
[Abstract]
[Full Text]
-
Baev, D., Li, X., Edgerton, M.
(2001). Genetically engineered human salivary histatin genes are functional in Candida albicans: development of a new system for studying histatin candidacidal activity. Microbiology
147: 3323-3334
[Abstract]
[Full Text]
-
Edgerton, M., Koshlukova, S.E.
(2000). Salivary Histatin 5 and its Similarities to the Other Antimicrobial Proteins in Human Saliva. ADR
14: 16-21
[Abstract]